WCG Wealth Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
WCG Wealth Advisors's FBT Position: Q2 2026 in Review
WCG Wealth Advisors increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 12% in Q2 2026, buying an estimated $1.97M and bringing the position to 83,489 shares worth $20.7M. The position accounts for 0.49% of the portfolio, ranked #58.
WCG Wealth Advisors first reported a position in FBT in Q1 2026 and has held it in 2 quarters since. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- WCG Wealth Advisors held 83,489 shares of First Trust NYSE Arca Biotechnology Index Fund worth $20.7M as of Q2 2026.
- WCG Wealth Advisors bought 9,147 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.97M.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.49% of WCG Wealth Advisors's portfolio in Q2 2026, its #58 holding.
- WCG Wealth Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and has held it in 2 quarters since.
- 340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on WCG Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.